Neutrophil Elastase Causes Tissue Damage That Decreases Host Tolerance to Lung Infection with Burkholderia Species

PLoS Pathogens

Volumn 10, Issue 8, 2014, Pages

  Sahoo, Manoranjan ^a   del Barrio, Laura ^a   Miller, Mark A ^b   Re, Fabio ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; C REACTIVE PROTEIN; CD11B ANTIGEN; COLLAGEN; ELASTASE; IMMUNOGLOBULIN M; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOCYTE ELASTASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; SIVELESTAT; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BRONCHOALVEOLAR LAVAGE FLUID; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; LUNG EDEMA; LUNG INFECTION; MELIOIDOSIS; MOUSE; NONHUMAN; PYROPTOSIS; SURVIVAL; TISSUE INJURY; WESTERN BLOTTING; ANIMAL; BURKHOLDERIA INFECTION; C57BL MOUSE; DISEASE MODEL; ENZYMOLOGY; HOST PARASITE INTERACTION; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY; RESPIRATORY TRACT INFECTION;

ANIMALS; BLOTTING, WESTERN; BURKHOLDERIA INFECTIONS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HOST-PARASITE INTERACTIONS; LEUKOCYTE ELASTASE; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RESPIRATORY TRACT INFECTIONS;

EID: 84930986460     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004327     Document Type: Article

References (58)

1. Nathan C, Ding A, (2010) Nonresolving inflammation. Cell 140: 871–882.
2. Schneider DS, Ayres JS, (2008) Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat Rev Immunol 8: 889–895.
3. Medzhitov R, Schneider DS, Soares MP, (2012) Disease tolerance as a defense strategy. Science 335: 936–941.
4. Ayres JS, (2013) Inflammasome-microbiota interplay in host physiologies. Cell Host Microbe 14: 491–497.
5. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ, (2006) Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 4: 272–282.
6. Ceballos-Olvera I, Sahoo M, Miller MA, Del Barrio L, Re F, (2011) Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1beta is deleterious. PLoS Pathog 7: e1002452.
7. Koh GC, Weehuizen TA, Breitbach K, Krause K, de Jong HK, et al. (2013) Glyburide reduces bacterial dissemination in a mouse model of melioidosis. PLoS Negl Trop Dis 7: e2500.
8. Kewcharoenwong C, Rinchai D, Utispan K, Suwannasaen D, Bancroft GJ, et al. (2013) Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection. Sci Rep 3: 3363.
9. Haraga A, West TE, Brittnacher MJ, Skerrett SJ, Miller SI, (2008) Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei. Infect Immun 76: 5402–5411.
10. Brett PJ, DeShazer D, Woods DE, (1998) Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int J Syst Bacteriol 48 (Pt 1) 317–320.
11. Wiersinga WJ, Wieland CW, van der Windt GJ, de Boer A, Florquin S, et al. (2007) Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis. Infect Immun 75: 3739–3746.
12. Breitbach K, Wongprompitak P, Steinmetz I, (2011) Distinct roles for nitric oxide in resistant C57BL/6 and susceptible BALB/c mice to control Burkholderia pseudomallei infection. BMC Immunol 12: 20.
13. Breitbach K, Klocke S, Tschernig T, van Rooijen N, Baumann U, et al. (2006) Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect Immun 74: 6300–6309.
14. Miyagi K, Kawakami K, Saito A, (1997) Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei. Infect Immun 65: 4108–4113.
15. Herbold W, Maus R, Hahn I, Ding N, Srivastava M, et al. (2010) Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection. Infect Immun 78: 2620–2630.
16. Spehlmann ME, Dann SM, Hruz P, Hanson E, McCole DF, et al. (2009) CXCR2-dependent mucosal neutrophil influx protects against colitis-associated diarrhea caused by an attaching/effacing lesion-forming bacterial pathogen. J Immunol 183: 3332–3343.
17. Del Rio L, Bennouna S, Salinas J, Denkers EY, (2001) CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. J Immunol 167: 6503–6509.
18. Chanchamroen S, Kewcharoenwong C, Susaengrat W, Ato M, Lertmemongkolchai G, (2009) Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect Immun 77: 456–463.
19. Egan AM, Gordon DL, (1996) Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes. Infect Immun 64: 4952–4959.
20. Liu PJ, Chen YS, Lin HH, Ni WF, Hsieh TH, et al. (2013) Induction of mouse melioidosis with meningitis by CD11b+ phagocytic cells harboring intracellular B. pseudomallei as a Trojan horse. PLoS Negl Trop Dis 7: e2363.
21. Easton A, Haque A, Chu K, Lukaszewski R, Bancroft GJ, (2007) A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. J Infect Dis 195: 99–107.
22. Coeshott C, Ohnemus C, Pilyavskaya A, Ross S, Wieczorek M, et al. (1999) Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci U S A 96: 6261–6266.
23. Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, et al. (2007) NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130: 918–931.
24. Guma M, Ronacher L, Liu-Bryan R, Takai S, Karin M, et al. (2009) Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum 60: 3642–3650.
25. Crouch EC, (1998) Structure, biologic properties, and expression of surfactant protein D (SP-D). Biochim Biophys Acta 1408: 278–289.
26. Taylor MD, Van Dyke K, Bowman LL, Miles PR, Hubbs AF, et al. (2000) A characterization of amiodarone-induced pulmonary toxicity in F344 rats and identification of surfactant protein-D as a potential biomarker for the development of the toxicity. Toxicol Appl Pharmacol 167: 182–190.
27. Kunitake R, Kuwano K, Yoshida K, Maeyama T, Kawasaki M, et al. (2001) KL-6, surfactant protein A and D in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Respiration 68: 488–495.
28. Choi SM, McAleer JP, Zheng M, Pociask DA, Kaplan MH, et al. (2013) Innate Stat3-mediated induction of the antimicrobial protein Reg3gamma is required for host defense against MRSA pneumonia. J Exp Med 210: 551–561.
29. Raberg L, Sim D, Read AF, (2007) Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science 318: 812–814.
30. Ferreira A, Marguti I, Bechmann I, Jeney V, Chora A, et al. (2011) Sickle hemoglobin confers tolerance to Plasmodium infection. Cell 145: 398–409.
31. Jamieson AM, Pasman L, Yu S, Gamradt P, Homer RJ, et al. (2013) Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 340: 1230–1234.
32. Dela Cruz CS, Liu W, He CH, Jacoby A, Gornitzky A, et al. (2012) Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses. Cell Host Microbe 12: 34–46.
33. Belaaouaj A, (2002) Neutrophil elastase-mediated killing of bacteria: lessons from targeted mutagenesis. Microbes Infect 4: 1259–1264.
34. Weinrauch Y, Drujan D, Shapiro SD, Weiss J, Zychlinsky A, (2002) Neutrophil elastase targets virulence factors of enterobacteria. Nature 417: 91–94.
35. Kessenbrock K, Dau T, Jenne DE, (2011) Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response. J Mol Med (Berl) 89: 23–28.
36. Pham CT, (2006) Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 6: 541–550.
37. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, et al. (2004) Neutrophil extracellular traps kill bacteria. Science 303: 1532–1535.
38. Brinkmann V, Zychlinsky A, (2012) Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biol 198: 773–783.
39. Fang H, Sun C, Xu L, Owen RJ, Auth RD, et al. (2010) Neutrophil elastase mediates pathogenic effects of anthrax lethal toxin in the murine intestinal tract. J Immunol 185: 5463–5467.
40. Vethanayagam RR, Almyroudis NG, Grimm MJ, Lewandowski DC, Pham CT, et al. (2011) Role of NADPH oxidase versus neutrophil proteases in antimicrobial host defense. PLoS One 6: e28149.
41. Abraham E, (2003) Neutrophils and acute lung injury. Crit Care Med 31: S195–199.
42. Zemans RL, Colgan SP, Downey GP, (2009) Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol 40: 519–535.
43. Moraes TJ, Zurawska JH, Downey GP, (2006) Neutrophil granule contents in the pathogenesis of lung injury. Curr Opin Hematol 13: 21–27.
44. Grommes J, Soehnlein O, (2011) Contribution of neutrophils to acute lung injury. Mol Med 17: 293–307.
45. Jiang D, Wenzel SE, Wu Q, Bowler RP, Schnell C, et al. (2013) Human neutrophil elastase degrades SPLUNC1 and impairs airway epithelial defense against bacteria. PLoS One 8: e64689.
46. Henke MO, John G, Rheineck C, Chillappagari S, Naehrlich L, et al. (2011) Serine proteases degrade airway mucins in cystic fibrosis. Infect Immun 79: 3438–3444.
47. von Bredow C, Wiesener A, Griese M, (2003) Proteolysis of surfactant protein D by cystic fibrosis relevant proteases. Lung 181: 79–88.
48. Kozik A, Moore RB, Potempa J, Imamura T, Rapala-Kozik M, et al. (1998) A novel mechanism for bradykinin production at inflammatory sites. Diverse effects of a mixture of neutrophil elastase and mast cell tryptase versus tissue and plasma kallikreins on native and oxidized kininogens. J Biol Chem 273: 33224–33229.
49. Sakata Y, Akaike T, Suga M, Ijiri S, Ando M, et al. (1996) Bradykinin generation triggered by Pseudomonas proteases facilitates invasion of the systemic circulation by Pseudomonas aeruginosa. Microbiol Immunol 40: 415–423.
50. Oehmcke S, Herwald H, (2010) Contact system activation in severe infectious diseases. J Mol Med (Berl) 88: 121–126.
51. Hirche TO, Atkinson JJ, Bahr S, Belaaouaj A, (2004) Deficiency in neutrophil elastase does not impair neutrophil recruitment to inflamed sites. Am J Respir Cell Mol Biol 30: 576–584.
52. Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, et al. (2010) Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 11: 1136–1142.
53. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, et al. (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10: 1366–1373.
54. Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, et al. (2006) Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2: e53.
55. Hase CC, Finkelstein RA, (1993) Bacterial extracellular zinc-containing metalloproteases. Microbiol Rev 57: 823–837.
56. Shaw L, Wiedow O, (2011) Therapeutic potential of human elafin. Biochem Soc Trans 39: 1450–1454.
57. Motta JP, Bermudez-Humaran LG, Deraison C, Martin L, Rolland C, et al. (2012) Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci Transl Med 4: 158ra144.
58. Corteling R, Wyss D, Trifilieff A, (2002) In vivo models of lung neutrophil activation. Comparison of mice and hamsters. BMC Pharmacol 2: 1.